B. Demir Et Al. , "Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk?," 41st FEBS Congress on Molecular and Systems Biology for a Better Life , vol.283, Kusadasi, Turkey, pp.69, 2016
Demir, B. Et Al. 2016. Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk?. 41st FEBS Congress on Molecular and Systems Biology for a Better Life , (Kusadasi, Turkey), 69.
Demir, B., Aktas, S., ALTUN, Z. S., Ercetin, P., & Olgun, N., (2016). Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk? . 41st FEBS Congress on Molecular and Systems Biology for a Better Life (pp.69). Kusadasi, Turkey
Demir, B. Et Al. "Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk?," 41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 2016
Demir, B. Et Al. "Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk?." 41st FEBS Congress on Molecular and Systems Biology for a Better Life , Kusadasi, Turkey, pp.69, 2016
Demir, B. Et Al. (2016) . "Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk?." 41st FEBS Congress on Molecular and Systems Biology for a Better Life , Kusadasi, Turkey, p.69.
@conferencepaper{conferencepaper, author={B. Demir Et Al. }, title={Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk?}, congress name={41st FEBS Congress on Molecular and Systems Biology for a Better Life}, city={Kusadasi}, country={Turkey}, year={2016}, pages={69} }